Stephens Believes Steris Corp (NYSE: STE) Won’t Stop Here

By Jason Carr

Stephens analyst Chris Cooley reiterated a Buy rating on Steris Corp (STEResearch Report) yesterday and set a price target of $135. The company’s shares opened today at $120.54, close to its 52-week high of $123.50.

According to TipRanks.com, Cooley is a 5-star analyst with an average return of 30.1% and a 68.4% success rate. Cooley covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Cooper Co, and Sientra.

Currently, the analyst consensus on Steris Corp is a Hold with an average price target of $126.

See today’s analyst top recommended stocks >>

Steris Corp’s market cap is currently $10.21B and has a P/E ratio of 32.68. The company has a Price to Book ratio of 3.27.

Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

STERIS Plc engages in the provision of infection prevention and other procedural products and services. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies.